{"title":"克服恶性胶质瘤治疗挑战:纳米载体介导的免疫检查点阻断剂经鼻途径递送","authors":"Hatem A.F.M Hassan","doi":"10.23880/nnoa-16000249","DOIUrl":null,"url":null,"abstract":"Malignant glioma represents a prevailing malignancy within both paediatric and adult populations, necessitating advanced therapeutic interventions. Traditional therapeutic avenues encompassing surgical resection, radiotherapy, and chemotherapy have yielded unsatisfactory clinical outcomes","PeriodicalId":286628,"journal":{"name":"Nanomedicine & Nanotechnology Open Access","volume":"83 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Overcoming Malignant Glioma Therapeutic Challenges: Nanocarrier-Mediated Delivery of Immune Checkpoint Blockers via Nasal Route\",\"authors\":\"Hatem A.F.M Hassan\",\"doi\":\"10.23880/nnoa-16000249\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Malignant glioma represents a prevailing malignancy within both paediatric and adult populations, necessitating advanced therapeutic interventions. Traditional therapeutic avenues encompassing surgical resection, radiotherapy, and chemotherapy have yielded unsatisfactory clinical outcomes\",\"PeriodicalId\":286628,\"journal\":{\"name\":\"Nanomedicine & Nanotechnology Open Access\",\"volume\":\"83 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanomedicine & Nanotechnology Open Access\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/nnoa-16000249\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine & Nanotechnology Open Access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/nnoa-16000249","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Overcoming Malignant Glioma Therapeutic Challenges: Nanocarrier-Mediated Delivery of Immune Checkpoint Blockers via Nasal Route
Malignant glioma represents a prevailing malignancy within both paediatric and adult populations, necessitating advanced therapeutic interventions. Traditional therapeutic avenues encompassing surgical resection, radiotherapy, and chemotherapy have yielded unsatisfactory clinical outcomes
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
